Search Results - M. Fehr
- Showing 1 - 3 results of 3
-
1
The influence of bevacizumab on platelet function by M Fehr, S Catschegn, J Madon, L Asmis, R Cathomas, Moos von
Published in Swiss Medical Weekly (2011-07-01)Get full text
Article -
2
P268 Impact of the 2020 COVID-19 lockdown in Switzerland on physical activity in patients with early breast cancer under aromatase-inhibitor therapy. A subanalysis of the SAKK 95/1... by N. Hoefnagels, A. Gautier, A. Müller, S. Schär, L. Rosset, N. Corke Mahbiz, M. Schwitter, U. Güth, A. Jakob, C. Balmelli-Cattelan, C. Leo, M. Fehr, D.R. Thorn, S. Riniker, A. Chouiter-Djebaili, J. Musilova, F. Honecker
Published in Breast (2023-03-01)Get full text
Article -
3
Retrospective multicenter analysis comparing conventional with oncoplastic breast conservation: oncologic and surgical outcome in women with high risk breast cancer from the OPBC-0... by F. Fitzal, M. Bolliger, D. Dunkler, L. Gambone, J. Heil, F. Riedel, J. de Boniface, C. André, Z. Matrai, D. Pukancsik, R.R. Paulinelli, V. Ostapenko, A. Burneckis, A. Ostapenko, E. Ostapenko, F. Meani, Y. Harder, M. Bonollo, A.S.M. Alberti, C. Tausch, B. Papassotiropoulos, R. Helfgott, D. Heck, H.J. Fehrer, M. Acko, P. Schrenk, G. Montagna, E. Trapp, G. Pristauz, C. Paliczek, J.U. Blohmer, S. Steffen, L. Romics, E. Morrow, K. Lorenz, M. Fehr, M. Ritter, W.P. Weber
Published in Breast (2021-04-01)Get full text
Article
